Akebia Therapeutics (AKBA)

$1.13 0.04 (3.42%)

16:00 EST AKBA Stock Quote Delayed 30 Minutes

Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom

By Yiannis Zourmpanos, InvestorPlace Contributor Jul 6, 2023

Are you looking for High Return Penny Stocks for high growth? Here are three penny stocks with rapid development and great market potential.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?

More Articles

Volume:

Previous Close -

Market Cap 197.23M

PE Ratio -3.42

EPS -0.33

Volume (Avg. Vol.) 889,359

Day's Range $1.12 - $1.18

52-Week Range $0.30 - $1.84

Dividend & Yield N/A (N/A)

AKBA Stock Predictions, Articles, and Akebia Therapeutics News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 1, 2022

Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday!

Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2022

AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jun 29, 2022

Good morning, trader! With the start of another day comes our breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 15, 2022

It's time for another breakdown of the biggest pre-market stock movers as we get ready for the opening bell on Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 16, 2022

Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday!

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

7 Speculative Penny Stocks Worth a Roll of the Dice

By Josh Enomoto, InvestorPlace Contributor Feb 25, 2022

Under any circumstance, penny stocks are extremely risky. However, their under-the-radar profile could be intriguing right now.

7 Small-Cap Stocks to Buy From the Beat-Up Bargain Bin

By Chris Lau, InvestorPlace Contributor Oct 11, 2021

Unwilling to wait for catalysts, some investors threw these small-cap stocks into the garbage bin. But that doesn't mean they won't succeed.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 1, 2021

Welcome back from the holiday weekend and let's get right into it with a look at the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Apr 29, 2021

Good morning! We're getting ready for another day of trading with a list of the top pre-market stock movers for Thursday.

5 “Strong Buy” Biotech Stocks With More Than 80% Upside

By Maya Sasson, Writer, TipRanks Nov 27, 2019

For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.

5 Healthcare Stocks That Are Down, But Not Out!

By Josh Enomoto, InvestorPlace Contributor Aug 29, 2018

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

Akebia Therapeutics Inc (AKBA) and Babcock & Wilcox Enterprises Inc (BW) Lead 18 Investor Reports

By Fintel May 23, 2017

13D and 13G filings are windows into activist investor activities. We look at 18 notable filings....

Akebia stock gains as H.C. Wainwright upgrades (NASDAQ:AKBA)

From Seeking Alpha Aug 28, 2023

Akebia Therapeutics (AKBA) shares rose on Monday after H.C. Wainwright upgraded it, expecting FDA nod for its kidney disease candidate, vadadustat. Read more here.

Akebia to resubmit FDA application for kidney drug by end of Q3 (AKBA)

From Seeking Alpha Jul 18, 2023

Akebia Therapeutics (AKBA) said it plans to resubmit its market application to the FDA by the end of Q3 for its kidney disease drug vadadustat. Read more here.

Akebia Therapeutics announces new finance chief (NASDAQ:AKBA)

From Seeking Alpha Jun 13, 2023

Biopharmaceutical company, Akebia Therapeutics (AKBA) said that Ellen Snow is joining as new senior VP, CFO and Treasurer, beginning on July 17, 2023.Ms

Akebia settles last patent lawsuit related to kidney disease therapy (NASDAQ:AKBA)

From Seeking Alpha Jun 2, 2023

Akebia Therapeutics (AKBA) announced Friday that its subsidiary Keryx Biopharmaceuticals and licensing partner Panion & BF Biotech settled the last patent litigation related to...

Why Shares of Akebia Therapeutics Were Up Tuesday

From The Motley Fool May 23, 2023

An approval in the U.K. for Akebia's symptomatic anemia therapy boosted the stock.

H.C. Wainwright Keeps Their Hold Rating on Akebia Therapeutics (AKBA)

From TipRanks Nov 4, 2022

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Akebia Therapeutics (AKBA – Research Report) today and set a price target of $1.25. The company&#8...

ADVERTISEMENT